Business executives from startups and growth-stage companies can network and share information at The North Carolina Nanotechnology Commercialization Conference’s Nanomedicine Commercialization Workshop on strategies for company building and moving to market.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts. Now here's the best of what YOU had to say:
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts. Now here's the best of what YOU had to say:
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts. Now here's the best of what YOU had to say:
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: A handful of investment firms are interested in Brea, California, company Beckman Coulter, and the top 10 IT implications of healthcare reform.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: top IT implications of healthcare reform and could FDA staffers be fired because they're smarter than the boss?
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Many medical technologies never realize their full potential because the factors that limit broad adoption are not fully understood and addressed. This is why many technologies realize no more than 15-20% of their true potential, despite massive investments and nearly heroic efforts of the sales, marketing and leadership teams.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week:
The Ohio Venture Association will focus on the world of biomedical technology when Frank Douglas, President and CEO of the Akron BioInnovation Institute, speaks at its upcoming lunch meeting.
One of the biggest issues today in medical technology is not regulatory, or reimbursement, or the burden of clinical evidence; it is the lack of a sufficiently clear understanding of the market and market dynamics.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Symposium participants will have the opportunity to work with nationally recognized experts to identify and prioritize issues critical to ensuring that patient-centered high-value healthcare delivery practices thrive and spread.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: Medicare Advantage private fee-for-service plans are a waste of taxpayer money, and GE Healthcare's eHealth VP Earl Jones talks about health IT politics.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: Dr. Jan Gurley tells us what happens at a needle exchange, and Stryker Biotech gets blasted by prosecutors after asking for dismissal of criminal charges.
Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: No research yet to show stem cells help facelifts, and Harvard researchers find "reprogramming gene."
Health care reform, putting the patient first and identifying the best solutions will be among the issues discussed at the 2010 Mayo Clinic Health Policy Center Symposium "Achieving the Vision: Advancing High-Value Health Care."